Donglan Luo

799 total citations
38 papers, 473 citations indexed

About

Donglan Luo is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Donglan Luo has authored 38 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 14 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Donglan Luo's work include Lymphoma Diagnosis and Treatment (17 papers), Viral-associated cancers and disorders (5 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Donglan Luo is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), Viral-associated cancers and disorders (5 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Donglan Luo collaborates with scholars based in China, United States and Hong Kong. Donglan Luo's co-authors include Xin-lan Luo, Yan‐Hui Liu, Fangping Xu, Li‐Xu Yan, Jie Xu, Fen Zhang, Xiaolan Zhu, Chao Liu, Ping Mei and Jie Chen and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Human Pathology.

In The Last Decade

Donglan Luo

38 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donglan Luo China 11 174 162 143 107 101 38 473
Barbara Burroni France 9 224 1.3× 77 0.5× 107 0.7× 44 0.4× 109 1.1× 37 447
D. Violot France 11 108 0.6× 124 0.8× 79 0.6× 59 0.6× 71 0.7× 15 352
Bariş Boyraz United States 12 134 0.8× 277 1.7× 57 0.4× 50 0.5× 80 0.8× 27 619
Sang‐Woo Juhng South Korea 16 177 1.0× 285 1.8× 197 1.4× 130 1.2× 154 1.5× 32 795
Elise Gradhand Germany 12 205 1.2× 282 1.7× 54 0.4× 147 1.4× 81 0.8× 35 549
Hongmei Yi China 11 188 1.1× 152 0.9× 194 1.4× 55 0.5× 23 0.2× 39 423
Giovanni Crisafulli Italy 12 176 1.0× 176 1.1× 93 0.7× 217 2.0× 117 1.2× 32 493
Atsuro Sugita Japan 12 178 1.0× 173 1.1× 46 0.3× 61 0.6× 53 0.5× 27 456
Silvana Compasso Italy 10 103 0.6× 161 1.0× 92 0.6× 28 0.3× 98 1.0× 10 489
Aslı Çakır Türkiye 11 172 1.0× 81 0.5× 72 0.5× 71 0.7× 133 1.3× 49 447

Countries citing papers authored by Donglan Luo

Since Specialization
Citations

This map shows the geographic impact of Donglan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donglan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donglan Luo more than expected).

Fields of papers citing papers by Donglan Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donglan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donglan Luo. The network helps show where Donglan Luo may publish in the future.

Co-authorship network of co-authors of Donglan Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Donglan Luo. A scholar is included among the top collaborators of Donglan Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donglan Luo. Donglan Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Su, Fen Zhang, Yu Chen, et al.. (2022). Fbw7 Inhibits the Progression of Activated B-Cell Like Diffuse Large B-Cell Lymphoma by Targeting the Positive Feedback Loop of the LDHA/lactate/miR-223 Axis. Frontiers in Oncology. 12. 842356–842356. 10 indexed citations
2.
Li, Ling, et al.. (2018). Acquired hypophosphatemic osteomalacia is easily misdiagnosed or neglected by rheumatologists: A report of 9 cases. Experimental and Therapeutic Medicine. 15(6). 5389–5393. 7 indexed citations
3.
Chen, Pingping, et al.. (2017). Pathologically confirmed pulmonary Actinomycosis in 11 cases: clinical features and misdiagnosis analysis. Zhonghua laonian yixue zazhi. 36(5). 537–542. 1 indexed citations
4.
Chen, Gang, et al.. (2017). 18 F-FDG PET/CT and contrast-enhanced CT findings of pulmonary cryptococcosis. European Journal of Radiology. 89. 140–148. 26 indexed citations
5.
Yao, Su, Fangping Xu, Yu Chen, et al.. (2017). Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation. Journal of Experimental & Clinical Cancer Research. 36(1). 10–10. 25 indexed citations
6.
Yan, Jinhai, Donglan Luo, Fen Zhang, et al.. (2017). Diffuse large B cell lymphoma associated with chronic inflammation arising within atrial myxoma: aggressive histological features but indolent clinical behaviour. Histopathology. 71(6). 951–959. 18 indexed citations
7.
Yan, Li‐Xu, Yan‐Hui Liu, Jianwen Xiang, et al.. (2015). PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. International Journal of Oncology. 48(2). 471–484. 97 indexed citations
8.
Guo, Shuangping, John K. C. Chan, Javeed Iqbal, et al.. (2014). EZH2 Mutations in Follicular Lymphoma from Different Ethnic Groups and Associated Gene Expression Alterations. Clinical Cancer Research. 20(12). 3078–3086. 30 indexed citations
9.
10.
Yan, Li‐Xu, Yan‐Hui Liu, Donglan Luo, et al.. (2014). MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified. PLoS ONE. 9(8). e104068–e104068. 65 indexed citations
11.
Zhang, Fen, Li‐Xu Yan, Su-Xia Lin, et al.. (2013). Immunophenotypic features and t(14;18) (q32;q21) translocation of Chinese follicular lymphomas helps to distinguish subgroups. Diagnostic Pathology. 8(1). 154–154. 3 indexed citations
12.
Luo, Donglan, Yan‐Hui Liu, Fen Zhang, et al.. (2013). [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].. PubMed. 42(9). 584–8. 3 indexed citations
13.
Xu, Fangping, Yan‐Hui Liu, Donglan Luo, et al.. (2011). [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].. PubMed. 40(9). 616–21. 3 indexed citations
14.
Luo, Donglan, Yan‐Hui Liu, Li Li, et al.. (2011). [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].. PubMed. 40(4). 235–9. 3 indexed citations
15.
Wu, Hongmei, Yan‐Hui Liu, Lin Feng, et al.. (2011). [Association of HER2 protein expression with clinicopathologic features and prognosis in Chinese patients with gastric carcinoma].. PubMed. 40(5). 296–9. 10 indexed citations
16.
17.
Zhang, Caojin, Yigao Huang, Stefan Bertog, et al.. (2011). Experimental Study of the Spider™ Patent Foramen Ovale Occluder. Cerebrovascular Diseases. 32(1). 51–56. 1 indexed citations
18.
Zhong, Wen‐Zhao, Yi‐Long Wu, Xue-Ning Yang, et al.. (2010). Genetic Evolution of Epidermal Growth Factor Receptor in Adenocarcinoma With a Bronchioloalveolar Carcinoma Component. Clinical Lung Cancer. 11(3). 160–168. 7 indexed citations
19.
Liu, Yan‐Hui, Fangping Xu, Jianyu Rao, et al.. (2009). Justification of the Change From 10% to 30% for the Immunohistochemical HER2 Scoring Criterion in Breast Cancer. American Journal of Clinical Pathology. 132(1). 74–79. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Burroni Breakdown of academic impact, for papers by D. Violot Breakdown of academic impact, for papers by Bariş Boyraz Breakdown of academic impact, for papers by Sang‐Woo Juhng Breakdown of academic impact, for papers by Elise Gradhand Breakdown of academic impact, for papers by Hongmei Yi Breakdown of academic impact, for papers by Giovanni Crisafulli Breakdown of academic impact, for papers by Atsuro Sugita Breakdown of academic impact, for papers by Silvana Compasso Breakdown of academic impact, for papers by Aslı Çakır
Rankless by CCL
2026